Inhibitory effects of mevastatin and a geranylgeranyl transferase I inhibitor (GGTI-2166) on mononuclear osteoclast formation induced by receptor activator of NFκB ligand (RANKL) or tumor necrosis factor-α (TNF-α)-Reference-Cited by-同舟云学术

Inhibitory effects of mevastatin and a geranylgeranyl transferase I inhibitor (GGTI-2166) on mononuclear osteoclast formation induced by receptor activator of NFκB ligand (RANKL) or tumor necrosis factor-α (TNF-α)

Published:2005-01 Issue:1 Volume:69 Page:87-95
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Woo Je-Tae,Nakagawa Hiroshi,Krecic Annette M.,Nagai Kazuo,Hamilton Andrew D.,Sebti Said M.,Stern Paula H.

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference39 articles.

1. Modulation of osteoclast differentiation;Suda;Endocr Rev,1992

2. Regulation of the differentiation and function of osteoclasts;Chambers;J Pathology,2000

3. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families;Suda;Endocr Rev,1999

4. Regulation of osteoclast function;Suda;J Bone Miner Res,1997

5. Rho: theme and variations;Ridly;Curr Biol,1996

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the RAS upstream and downstream signaling pathway for cancer treatment;European Journal of Pharmacology;2024-09

2. In-Silico analysis to identify the potent inhibitor of Rho GTPase activating protein for the usage of the Glaucoma;Materials Today: Proceedings;2021

3. Regulation of Small GTPase Prenylation in the Nervous System;Molecular Neurobiology;2020-01-27

4. Surrogate Outcome Measures of In Vitro Osteoclast Resorption of β Tricalcium Phosphate;Advanced Healthcare Materials;2016-12-08

5. Atorvastatin Reduces Circulating Osteoprogenitor Cells and T-Cell RANKL Expression in Osteoporotic Women: Implications for the Bone-Vascular Axis;Cardiovascular Therapeutics;2016-01-08